• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXHS2400123 马昔腾坦他达拉非片 macitentan;tadalafil Tablet Chemical Drugs(5.1) Import Drug Application 2025-01-01 Johnson & Johnson;Penn Pharmaceutical Services Ltd;Janssen-Cilag International NV view
JXHS2400122 马昔腾坦他达拉非片 macitentan;tadalafil Tablet Chemical Drugs(5.1) Import Drug Application 2025-01-01 Johnson & Johnson;Penn Pharmaceutical Services Ltd;Janssen-Cilag International NV view
JTH2400080 马昔腾坦他达拉非片 macitentan;tadalafil Tablet Chemical Drugs Disposable Import Drug Application 2024-06-08 Johnson & Johnson Pharmaceutical Co Ltd;Janssen-Cilag AG;Penn Pharmaceutical Services Ltd view
JTH2400079 马昔腾坦他达拉非片 macitentan;tadalafil Tablet Chemical Drugs Disposable Import Drug Application 2024-06-08 Johnson & Johnson Pharmaceutical Co Ltd;Janssen-Cilag AG;Penn Pharmaceutical Services Ltd view
JXHL2300281 马昔腾坦他达拉非片 macitentan;tadalafil Tablet Chemical Drugs(2.3) Import Drug Application 2023-11-10 Actelion Pharmaceuticals Ltd;Johnson & Johnson (CHINA) Investment Ltd view
JXHB2101042 马昔腾坦他达拉非片 macitentan;tadalafil Tablet Chemical Drugs(2.3) Supplementary Application 2021-07-26 Actelion Pharmaceuticals Ltd;Penn Pharmaceutical Services Ltd view
JXHL2000344 马昔腾坦他达拉非片 macitentan;tadalafil Tablet Chemical Drugs(2.3) Import Drug Application 2020-12-25 Actelion Pharmaceuticals Ltd Actelion Pharmaceuticals Ltd In Review 2020-12-23 view